XYL Xylem Inc.
Pumps & Pumping Equipment · NYSE · SEC CIK 1524472 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.9%
TTM net income YoY14.1%
TTM EPS YoY16.2%
Revenue 3-yr CAGR10.3%
Net income 3-yr CAGR30.0%
Margins
Gross margin39.8%
Operating margin15.1%
Net margin11.9%
FCF margin10.2%
EBITDA margin21.3%
Returns
ROE10.1%
ROA6.3%
ROIC (approx.)9.0%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets39.3%
Debt / equity0.28x
Current ratio1.39x
Interest coverage36.11x
Cash quality & payout
Operating cash flow / net income1.18x
Accruals ratio-1.1%
Payout ratio37.4%
Capex / revenue3.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $9.04B | $8.56B |
| Cost of revenue | $5.56B | $5.35B |
| Gross profit | $3.48B | $3.21B |
| R&D expense | $226.00M | $230.00M |
| SG&A expense | $1.92B | $1.91B |
| Operating income | $1.22B | $1.01B |
| Interest expense | $29.00M | $44.00M |
| Pretax income | $1.18B | $1.09B |
| Income tax | $231.00M | $197.00M |
| Net income | $957.00M | $890.00M |
| EBITDA | $1.80B | $1.57B |
| EPS (basic) | 3.93 | 3.67 |
| EPS (diluted) | 3.92 | 3.65 |
| Dividends declared per share | 1.60 | 1.44 |
| Weighted avg. shares (diluted) | 243.99M | 243.52M |
| Balance sheet | ||
| Cash & equivalents | $1.48B | $1.12B |
| Receivables | $1.76B | $1.67B |
| Inventory | $983.00M | $996.00M |
| Current assets | $4.64B | $4.10B |
| PP&E, net | $1.16B | $1.15B |
| Goodwill | $8.33B | $7.98B |
| Intangibles | $2.27B | $2.38B |
| Total assets | $17.63B | $16.49B |
| Current liabilities | $2.86B | $2.34B |
| Short-term debt | $534.00M | $38.00M |
| Long-term debt | $1.41B | $1.98B |
| Total debt | $1.94B | $2.02B |
| Total liabilities | $5.88B | $5.61B |
| Shareholders' equity | $11.48B | $10.64B |
| Net debt | $463.00M | $895.00M |
| Shares outstanding | 243.58M | 242.99M |
| Cash flow statement | ||
| Operating cash flow | $1.24B | $1.26B |
| Capital expenditure | $331.00M | $321.00M |
| Free cash flow | $910.00M | $942.00M |
| Investing cash flow | -$471.00M | -$482.00M |
| Financing cash flow | -$501.00M | -$615.00M |
| Depreciation & amortization | $575.00M | $562.00M |
| Stock-based compensation | $53.00M | $56.00M |
| Dividends paid | $391.00M | $350.00M |
| Share buybacks | $15.00M | $20.00M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.